Author:
van de Donk N W C J,Kamphuis M M J,van Dijk M,Borst H P E,Bloem A C,Lokhorst H M
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference64 articles.
1. Dalton, WS & Jove, R Drug resistance in multiple myeloma: approaches to circumvention. Semin Oncol, (1999). 26 (5 Suppl. 13), 23–27.
2. Epstein, J, Xiao, HQ & Oba, BK P-glycoprotein expression in plasma-cell myeloma is associated with resistance to VAD. Blood, (1989). 74, 913–917.
3. Sonneveld, P, Durie, BG, Lokhorst, HM, Marie, JP, Solbu, G, Suciu, S, Zittoun, R, Lowenberg, B & Nooter, K Modulation of multidrug-resistant multiple myeloma by cyclosporin. The Leukaemia Group of the EORTC and the HOVON. Lancet, (1992). 340, 255–259.
4. Grogan, TM, Spier, CM, Salmon, SE, Matzner, M, Rybski, J, Weinstein, RS, Scheper, RJ & Dalton, WS P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapy. Blood, (1993). 81, 490–495.
5. Raaijmakers, HG, Izquierdo, MA, Lokhorst, HM, de Leeuw, C, Belien, JA, Bloem, AC, Dekker, AW, Scheper, RJ & Sonneveld, P Lung-resistance-related protein expression is a negative predictive factor for response to conventional low but not to intensified dose alkylating chemotherapy in multiple myeloma. Blood, (1998). 91, 1029–1036.
Cited by
74 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献